Detecting Common BRCA1/2 Mutations in Spanish Families
Author Information
Author(s): Sandra Filippini, Ana Blanco, Ana Fernández-Marmiesse, Vanesa Álvarez-Iglesias, Clara Ruíz-Ponte, Ángel Carracedo, Ana Vega
Primary Institution: Unidade de Xenética, Instituto de Medicina Legal & Grupo de Medicina Xenómica, Facultad de Medicina, Santiago de Compostela, Galicia, Spain
Hypothesis
Can a multiplex SNaPshot assay effectively detect common BRCA1 and BRCA2 mutations in Spanish breast and ovarian cancer families?
Conclusion
The developed SNaPshot assay is a sensitive, rapid, and cost-effective method for identifying common BRCA1 and BRCA2 mutations in Spanish families.
Supporting Evidence
- The SNaPshot reaction was concordant with direct sequencing results.
- The assay can analyze approximately 50% of mutations responsible for breast/ovarian cancer in Spanish families.
- The method is suitable for high-throughput genotyping.
Takeaway
Scientists created a quick and cheap test to find common gene changes that can cause breast and ovarian cancer in families from Spain.
Methodology
A multiplex SNaPshot reaction was developed to target ten recurrent and founder mutations in BRCA1 and BRCA2 genes.
Limitations
The study only included Spanish families and may not be applicable to other populations.
Participant Demographics
48 DNA samples from Spanish breast and ovarian cancer patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website